Conolidine’s analgesic consequences stem from its conversation with non-opioid pain pathways. Compared with opioids, which bind to µ-opioid receptors during the central nervous procedure, conolidine modulates alternate molecular targets. A Science Innovations review identified that conolidine interacts Together with the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid p... https://pierreq975psu7.wikilima.com/user